NCT02995473 - Efficacy and Safety Study of NP000888 in Subjects With Plaque and Nail Psoriasis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 8, 2017

Primary Completion Date

May 3, 2018

Study Completion Date

May 28, 2018

Conditions

Psoriasis

Interventions

DRUG

NP000888

270 µg/g topical (BID) for 24 weeks

DRUG

Vehicle

Topical (BID) for 24 weeks

Trial Locations (10)

Galderma Investigational Site, Lincuo

Galderma investigational site, New Taipei City

Galderma investigational site, Taichung

Galderma investigational site, Tainan City

Galderma investigational site 1, Taipei

Galderma investigational site 2, Taipei

Galderma investigational site 3, Taipei

Galderma investigational site 4, Taipei

Galderma investigational site 5, Taipei

Galderma investigational site 6, Taipei